Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Novartis Ag (NVSEF) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Novartis Ag (NVSEF) over the last 17 years, with Q4 2025 value amounting to 0.03.

  • Novartis Ag's Asset Utilization Ratio fell 9384.25% to 0.03 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.03, marking a year-over-year decrease of 9384.25%. This contributed to the annual value of 0.51 for FY2025, which is 278.3% up from last year.
  • Novartis Ag's Asset Utilization Ratio amounted to 0.03 in Q4 2025, which was down 9384.25% from 0.15 recorded in Q3 2025.
  • In the past 5 years, Novartis Ag's Asset Utilization Ratio ranged from a high of 0.5 in Q2 2024 and a low of 0.03 during Q4 2025
  • Over the past 5 years, Novartis Ag's median Asset Utilization Ratio value was 0.4 (recorded in 2022), while the average stood at 0.38.
  • In the last 5 years, Novartis Ag's Asset Utilization Ratio soared by 2775.92% in 2024 and then tumbled by 9384.25% in 2025.
  • Novartis Ag's Asset Utilization Ratio (Quarter) stood at 0.41 in 2021, then decreased by 3.65% to 0.39 in 2022, then increased by 8.7% to 0.43 in 2023, then rose by 14.43% to 0.49 in 2024, then tumbled by 93.84% to 0.03 in 2025.
  • Its Asset Utilization Ratio was 0.03 in Q4 2025, compared to 0.15 in Q3 2025 and 0.27 in Q2 2025.